These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8610774)

  • 41. Effects of hormone replacement therapy on the circadian pattern of atherothrombotic risk factors.
    Katz RJ; Hsia J; Walker P; Jacobs H; Kessler C
    Am J Cardiol; 1996 Oct; 78(8):876-80. PubMed ID: 8888658
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of oestrogen replacement therapy on haemostatic variables in postmenopausal women with non-insulin-dependent diabetes mellitus.
    Hahn L; Mattsson LA; Andersson B; Tengborn L
    Blood Coagul Fibrinolysis; 1999 Mar; 10(2):81-6. PubMed ID: 10192656
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hormone replacement therapy and hemostasis: effects in Brazilian postmenopausal women.
    Callejon DR; Franceschini SA; Montes MB; Toloi MR
    Maturitas; 2005; 52(3-4):249-55. PubMed ID: 16257613
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in hemostatic variables induced by estrogen replacement therapy: comparison of transdermal and oral administration in a crossover-designed study.
    Fait T; Vrablik M; Zizka Z; Kostirova M
    Gynecol Obstet Invest; 2008; 65(1):47-51. PubMed ID: 17713346
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential effect of the ultra-low dose and standard estrogen plus dydrogesterone therapy on thrombin generation and fibrinolysis in postmenopausal women.
    Piróg M; Jach R; Kacalska-Janssen O
    Acta Obstet Gynecol Scand; 2017 Dec; 96(12):1438-1445. PubMed ID: 28981954
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hormone replacement therapy in healthy postmenopausal women: a randomized, placebo-controlled study of effects on coagulation and fibrinolytic factors.
    Gottsäter A; Rendell M; Hulthén UL; Berntorp E; Mattiasson I
    J Intern Med; 2001 Mar; 249(3):237-46. PubMed ID: 11285043
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Positive impact of hormone replacement therapy on the fibrinolytic system: a long-term randomized controlled study in healthy postmenopausal women.
    Madsen JS; Kristensen SR; Gram J; Bladbjerg EM; Henriksen FL; Gram J; Christensen K; Jespersen J
    J Thromb Haemost; 2003 Sep; 1(9):1984-91. PubMed ID: 12941041
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
    Stephenson K; Neuenschwander PF; Kurdowska AK
    Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Auditory brainstem response in postmenopausal women treated with hormone replacement therapy: a pilot study.
    Caruso S; Cianci A; Grasso D; Agnello C; Galvani F; Maiolino L; Serra A
    Menopause; 2000; 7(3):178-83. PubMed ID: 10810963
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of estrogen therapy on insulin resistance and plasminogen activator inhibitor type 1 concentrations in postmenopausal women.
    Saucedo R; Basurto L; Zarate A; Martínez C; Hernandez M; Galván R
    Gynecol Obstet Invest; 2007; 64(2):61-4. PubMed ID: 17264514
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibitors and activation markers of the haemostatic system during hormone therapy: a comparative study of oral estradiol (2 mg)/ dydrogesterone and estradiol (2 mg)/ trimegestone.
    Norris LA; Brosnan J; Bonnar J; Conard J; Kluft C; Hellgren M
    Thromb Haemost; 2008 Aug; 100(2):253-60. PubMed ID: 18690345
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of specific hormones on fibrinolysis in pregnancy.
    Houlihan CM; Knuppel RA; Vintzileos AM; Guo JZ; Hahn DW
    Am J Obstet Gynecol; 1996 Jul; 175(1):168-72. PubMed ID: 8694045
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Regulatory effects of estetrol on the endothelial plasminogen pathway and endothelial cell migration.
    Montt-Guevara MM; Palla G; Spina S; Bernacchi G; Cecchi E; Campelo AE; Shortrede JE; Canu A; Simoncini T
    Maturitas; 2017 May; 99():1-9. PubMed ID: 28364860
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study.
    Sendağ F; Terek MC; Karadadaş N; Bilgin O
    J Reprod Med; 2001 Nov; 46(11):962-8. PubMed ID: 11762152
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in the lipoprotein profile in postmenopausal women receiving hormone replacement therapy. Effects of natural and synthetic progesterone.
    Chen FP; Lee N; Soong YK
    J Reprod Med; 1998 Jul; 43(7):568-74. PubMed ID: 9693406
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults.
    Johansson JO; Landin K; Johannsson G; Tengborn L; Bengtsson BA
    Thromb Haemost; 1996 Sep; 76(3):422-8. PubMed ID: 8883281
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The effects of postmenopausal hormone therapy on serum estrogen, progesterone, and sex hormone-binding globulin levels in healthy postmenopausal women.
    Edlefsen KL; Jackson RD; Prentice RL; Janssen I; Rajkovic A; O'Sullivan MJ; Anderson G
    Menopause; 2010; 17(3):622-9. PubMed ID: 20215977
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study.
    Perera M; Sattar N; Petrie JR; Hillier C; Small M; Connell JM; Lowe GD; Lumsden MA
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1140-3. PubMed ID: 11238498
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of progestogen and progestogen type on hemostasis measures in postmenopausal women: the Postmenopausal Estrogen/Progestin Intervention (PEPI) Study.
    Smith NL; Wiley JR; Legault C; Rice KM; Heckbert SR; Psaty BM; Tracy RP; Cushman M
    Menopause; 2008; 15(6):1145-50. PubMed ID: 19186375
    [No Abstract]   [Full Text] [Related]  

  • 60. Improved sensitivity to activated protein C following postmenopausal hormone replacement therapy.
    De Mitrio V; Marino R; Giannoccaro F; Galantino P; Cicinelli E
    Blood Coagul Fibrinolysis; 1998 Apr; 9(3):293-4. PubMed ID: 9663716
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.